BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan Baiyao

Reuters2025-12-29

BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With <a href="https://laohu8.com/S/000538">Yunnan Baiyao</a>

Dec 29 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 601607.SS:

SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN ($171.21 million), PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026

Source text

Further company coverage: 601607.SS

($1 = 7.0088 Chinese yuan renminbi)

(Reporting by Beijing Newsroom)

((yukun.zhang@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2595200920?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-29 15:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595200920","market":"us","top_or_hot":-1,"title":"BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan Baiyao","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With <a href=\"https://laohu8.com/S/000538\">Yunnan Baiyao</a></title></head><body><p><span>Dec 29 (Reuters)</span><span> - </span>Shanghai Pharmaceuticals Holding Co Ltd <span>601607.SS</span>:</p><ul><li><p>SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN ($171.21 million), PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026</p></li></ul><p>Source text</p><p>Further company coverage: <span>601607.SS</span></p><p>($1 = 7.0088 Chinese yuan renminbi)</p><p> (Reporting by Beijing Newsroom)</p><p> ((yukun.zhang@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan Baiyao</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan Baiyao\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-29 15:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With <a href=\"https://laohu8.com/S/000538\">Yunnan Baiyao</a></title></head><body><p><span>Dec 29 (Reuters)</span><span> - </span>Shanghai Pharmaceuticals Holding Co Ltd <span>601607.SS</span>:</p><ul><li><p>SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN ($171.21 million), PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026</p></li></ul><p>Source text</p><p>Further company coverage: <span>601607.SS</span></p><p>($1 = 7.0088 Chinese yuan renminbi)</p><p> (Reporting by Beijing Newsroom)</p><p> ((yukun.zhang@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nL4N3XZ0DC:1","article_id":"2595200920","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595200920","pubTimestamp":1766995020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan BaiyaoDec 29  - Shanghai Pharmaceuticals Holding Co Ltd 601607.SS:SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN , PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026Source textFurther company coverage: 601607.SS  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0188":"融资融券","BK0187":"一线龙头","BK0028":"国家队","BK0239":"医药制造","BK0175":"白马股","BK0164":"国企混改","BK0099":"上海本地重组","LU1807302812.USD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (USD) ACC","LU1993786604.SGD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (SGD) ACC","BK0209":"零售","LU1960683339.HKD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (HKD) ACC","BK0196":"行业龙头","BK0097":"医药电商","BK0020":"浦东新区","BK0012":"证金概念","BK0184":"上海国资改革","000538":"云南白药","BK0183":"MSCI概念"},"translate_title":"简报-上海医药将与云南白药续签框架协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":0.9,"000538":0.9},"content_text":"BRIEF-Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan BaiyaoDec 29 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 601607.SS:SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN ($171.21 million), PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026Source textFurther company coverage: 601607.SS($1 = 7.0088 Chinese yuan renminbi) (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2595200920","isCrawlerRequest":true}